Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer ( (Q72326598)
Jump to navigation
Jump to search
scientific article published on 01 January 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer ( |
scientific article published on 01 January 1995 |
Statements
Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office (English)
S S Burtles
D R Newell
R E Henrar
1 January 1995